focal brachytherapy

RADIATION3 trials

Sponsors

Nara Medical University, Institut Claudius Regaud, Herlev Hospital

Conditions

Localized Prostate CancerProstate Cancerprostate cancer

Phase 2

Phase II Study of Feasibility of Focal Therapy for Prostate Cancer of Good Prognosis With Permanent I125 Localized Implant.

CompletedNCT01902680

Institut Claudius RegaudLocalized Prostate Cancer

Start: 2013-08-23End: 2017-06-06Updated: 2026-04-14

Unknown Phase

Focal Brachytherapy for localized prostate cancer diagnosed by saturation biopsy

RecruitingJPRN-UMIN000044790

Nara Medical Universityprostate cancer

Start: 2021-07-09Target: 35Updated: 2026-06-29

Cancer of the Prostate Treated With Focal Implantation of a RadioactivE Source

Enrolling by invitationNCT06080113

Herlev HospitalProstate Cancer

Start: 2023-11-01End: 2037-06-01Target: 50Updated: 2026-09-16

Related Papers

Is multiparametric MRI able to characterize margin for focal brachytherapy in low-grade prostate cancer?

Journal of Clinical Oncology2017-02-20

Results from a phase II trial (NTC01902680) of ultrafocal brachytherapy for low/intermediate risk prostate cancer.

Journal of Clinical Oncology2017-02-20

Hemiablative Focal Low Dose Rate Brachytherapy: A Phase II Trial Protocol

JMIR Research Protocols2016-06-134 citations